Skip to main content
. 2018 Dec;8(6):698–704. doi: 10.21037/cdt.2018.09.13

Table 1. Prevalence of pathologies of MFS in children and young adults.

Pathology Prevalence (<18 y) (%) Prevalence (>18 y) (%) P (prevalence)
Dilatation of sinus Valsalva 73/115 (63.5) 24/34 (70.6) ns
Mitral valve prolapse 59/115 (51.3) 19/34 (55.9) ns
Ectopia lentis 21/115 (18.3) 8/34 (23.5) ns
Systemic features 54/115 (47.0) 18/34 (52.9) ns
Skin striae 27/115 (23.5) 19/34 (55.9) 0.002
Dural ectasia 37/69 (53.6) 19/31 (61.3) ns
Wrist and thumb sign 52/115 (45.2) 25/34 (73.5) 0.016
   Thumb sign 34/115 (29.6) 16/34 (47.1) ns
   Wrist sign 32/115 (27.8) 16/34 (47.1) ns
Chest asymmetry 47/115 (40.9) 21/34 (61.7) ns
Pectus excavatum 27/115 (32.2) 8/34 (23.5) ns
Pectus carinatum deformity 25/115 (21.7) 10/34 (29.4) ns
Scoliosis or thoracolumbar kyphosis 41/115 (35.7) 19/34 (55.9) ns
Reduced elbow extension 11/115 (9.6) 10/34 (29.4) 0.011
Protrusio acetabuli 9/115 (7.8) 2/34 (5.8) ns
Reduced upper segment/lower segment ratio and increased arm/height and no severe scoliosis 48/115 (41.7) 21/34 (61.8) ns
Plain pes planus 61/115 (53.0) 22/34 (64.7) ns
Hindfoot deformity 30/115 (26.1) 5/34 (14.7) ns
Facial features (3/5) (dolichocephaly, enophthalmos, downslanting palpebral fissures, malar hypoplasia, retrognathia) 31/115 (27.0) 13/34 (38.2) ns
Myopia >3 diopters 21/115 (18.3) 3/34 (8.8) ns
Pneumothorax 4/115 (3.5) 4/34 (11.8) ns

MFS, Marfan syndrome; y, years; ns, not significant.